Vimarsana
Biggest News Aggregation in the World

Page 4 - Jb Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jb Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jb Pharma Today - Breaking & Trending Today

Common Entrance Examination (CEE) for D Pharma and B Pharma on June 25 - Vimarsana News

Common Entrance Examination (CEE) for D Pharma and B Pharma on June 25

A Common Entrance Examination (CEE) for the selection of candidates for admission into Diploma in Pharmacy (D. Pharm) and Bachelor of Pharmacy (B. Pharma) courses

Indore: B Pharma student ends life after friend stops talking to him - Vimarsana News

Indore: B Pharma student ends life after friend stops talking to him

Suicide note recovered from the spot

'Heart failure is no longer Life failure' as JB Pharma decreases price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 per cent - Vimarsana News

'Heart failure is no longer Life failure' as JB Pharma decreases price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 per cent

Mumbai (Maharashtra) [India], December 5 (ANI/PRNewswire): JB Chemicals & Pharmaceuticals Ltd (JB Pharma), one of the fastest-growing pharmaceutical companies in India, announced a substantial price decrease of approximately 50 per cent for the critical heart failure drug 'Azmarda'. Azmarda, which contains the patented molecule Saccubutril-Valsartan is indicated for Heart failure which ails 8 to 12 million people in the country. After the price reduction, Azmarda (Saccubutril-Valsartan), 50 mg will be available at Rs 39.6 per tablet as compared to Rs 78 per tablet. Commenting on th...

JB Pharma pledges to achieve ESG goals in its sustainability report - Vimarsana News

JB Pharma pledges to achieve ESG goals in its sustainability report

JB Chemicals & Pharmaceuticals Ltd. published its first sustainability report, where it underlined its dedication to achieving its environmental, social, and governance goals and disseminating responsible practices in its operations.

JB Pharma's revenue surges 30% in Q1, PAT declines - Vimarsana News

JB Pharma's revenue surges 30% in Q1, PAT declines

JB Pharma’s domestic formulations business grew at 34% in Q1, while international business revenue rose 28%

Related Topics:
Jb PharmaOrganic Growth